Edgewise Therapeutics (EWTX)
(Delayed Data from NSDQ)
$18.08 USD
+1.22 (7.21%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $19.53 +1.46 (8.05%) 5:04 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Brokerage Reports
Edgewise Therapeutics, Inc. [EWTX]
Reports for Purchase
Showing records 1 - 20 ( 82 total )
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Listen To Your Heart -- Takeaways From Management Dinner
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Steady As She Goes -- Can''t Wait For Summer To End (No, Really)
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Adding EWTX to Best Ideas List Ahead of Strong Catalyst Line-Up
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
How Does DMD Drug Development Change Post-Elevidys?
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Edgewise Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L